 | • レポートコード：MRC2-11QY04162 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はパーキンソン病のグローバル市場について調査・分析したレポートです。種類別（カルビドパ/レボドパ、ドーパミン受容体作動薬、MAO阻害薬）市場規模、用途別（病院、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別パーキンソン病の競争状況、市場シェア ・世界のパーキンソン病市場：種類別市場規模 2015年-2020年（カルビドパ/レボドパ、ドーパミン受容体作動薬、MAO阻害薬） ・世界のパーキンソン病市場：種類別市場規模予測 2021年-2026年（カルビドパ/レボドパ、ドーパミン受容体作動薬、MAO阻害薬） ・世界のパーキンソン病市場：用途別市場規模 2015年-2020年（病院、クリニック） ・世界のパーキンソン病市場：用途別市場規模予測 2021年-2026年（病院、クリニック） ・北米のパーキンソン病市場分析：米国、カナダ ・ヨーロッパのパーキンソン病市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのパーキンソン病市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のパーキンソン病市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのパーキンソン病市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Teva、Novartis、GSK、AbbVie、Merck、Boehringer Ingelheim、Amneal + Impax、Lundbeck、Sun Pharma、Wockhardt、UCB、Bausch Health、Acadia ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Parkinson’s Disease Market
The global Parkinson’s Disease market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Parkinson’s Disease Scope and Market Size
Parkinson’s Disease market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Parkinson’s Disease market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Teva
Novartis
GSK
AbbVie
Merck
Boehringer Ingelheim
Amneal + Impax
Lundbeck
Sun Pharma
Wockhardt
UCB
Bausch Health
Acadia
Market segment by Type, the product can be split into
Carbidopa/Levodopa
Dopamine Receptor Agonists
MAO-Inhibitors
Market segment by Application, split into
Hospitals
Clinics
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Parkinson’s Disease Revenue
1.4 Market by Type
1.4.1 Global Parkinson’s Disease Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Carbidopa/Levodopa
1.4.3 Dopamine Receptor Agonists
1.4.4 MAO-Inhibitors
1.5 Market by Application
1.5.1 Global Parkinson’s Disease Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Parkinson’s Disease Market Perspective (2015-2026)
2.2 Global Parkinson’s Disease Growth Trends by Regions
2.2.1 Parkinson’s Disease Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Parkinson’s Disease Historic Market Share by Regions (2015-2020)
2.2.3 Parkinson’s Disease Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Parkinson’s Disease Market Growth Strategy
2.3.6 Primary Interviews with Key Parkinson’s Disease Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Parkinson’s Disease Players by Market Size
3.1.1 Global Top Parkinson’s Disease Players by Revenue (2015-2020)
3.1.2 Global Parkinson’s Disease Revenue Market Share by Players (2015-2020)
3.1.3 Global Parkinson’s Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Parkinson’s Disease Market Concentration Ratio
3.2.1 Global Parkinson’s Disease Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Parkinson’s Disease Revenue in 2019
3.3 Parkinson’s Disease Key Players Head office and Area Served
3.4 Key Players Parkinson’s Disease Product Solution and Service
3.5 Date of Enter into Parkinson’s Disease Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Parkinson’s Disease Historic Market Size by Type (2015-2020)
4.2 Global Parkinson’s Disease Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Parkinson’s Disease Market Size by Application (2015-2020)
5.2 Global Parkinson’s Disease Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Parkinson’s Disease Market Size (2015-2020)
6.2 Parkinson’s Disease Key Players in North America (2019-2020)
6.3 North America Parkinson’s Disease Market Size by Type (2015-2020)
6.4 North America Parkinson’s Disease Market Size by Application (2015-2020)
7 Europe
7.1 Europe Parkinson’s Disease Market Size (2015-2020)
7.2 Parkinson’s Disease Key Players in Europe (2019-2020)
7.3 Europe Parkinson’s Disease Market Size by Type (2015-2020)
7.4 Europe Parkinson’s Disease Market Size by Application (2015-2020)
8 China
8.1 China Parkinson’s Disease Market Size (2015-2020)
8.2 Parkinson’s Disease Key Players in China (2019-2020)
8.3 China Parkinson’s Disease Market Size by Type (2015-2020)
8.4 China Parkinson’s Disease Market Size by Application (2015-2020)
9 Japan
9.1 Japan Parkinson’s Disease Market Size (2015-2020)
9.2 Parkinson’s Disease Key Players in Japan (2019-2020)
9.3 Japan Parkinson’s Disease Market Size by Type (2015-2020)
9.4 Japan Parkinson’s Disease Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Parkinson’s Disease Market Size (2015-2020)
10.2 Parkinson’s Disease Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Parkinson’s Disease Market Size by Type (2015-2020)
10.4 Southeast Asia Parkinson’s Disease Market Size by Application (2015-2020)
11 India
11.1 India Parkinson’s Disease Market Size (2015-2020)
11.2 Parkinson’s Disease Key Players in India (2019-2020)
11.3 India Parkinson’s Disease Market Size by Type (2015-2020)
11.4 India Parkinson’s Disease Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Parkinson’s Disease Market Size (2015-2020)
12.2 Parkinson’s Disease Key Players in Central & South America (2019-2020)
12.3 Central & South America Parkinson’s Disease Market Size by Type (2015-2020)
12.4 Central & South America Parkinson’s Disease Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Teva
13.1.1 Teva Company Details
13.1.2 Teva Business Overview
13.1.3 Teva Parkinson’s Disease Introduction
13.1.4 Teva Revenue in Parkinson’s Disease Business (2015-2020))
13.1.5 Teva Recent Development
13.2 Novartis
13.2.1 Novartis Company Details
13.2.2 Novartis Business Overview
13.2.3 Novartis Parkinson’s Disease Introduction
13.2.4 Novartis Revenue in Parkinson’s Disease Business (2015-2020)
13.2.5 Novartis Recent Development
13.3 GSK
13.3.1 GSK Company Details
13.3.2 GSK Business Overview
13.3.3 GSK Parkinson’s Disease Introduction
13.3.4 GSK Revenue in Parkinson’s Disease Business (2015-2020)
13.3.5 GSK Recent Development
13.4 AbbVie
13.4.1 AbbVie Company Details
13.4.2 AbbVie Business Overview
13.4.3 AbbVie Parkinson’s Disease Introduction
13.4.4 AbbVie Revenue in Parkinson’s Disease Business (2015-2020)
13.4.5 AbbVie Recent Development
13.5 Merck
13.5.1 Merck Company Details
13.5.2 Merck Business Overview
13.5.3 Merck Parkinson’s Disease Introduction
13.5.4 Merck Revenue in Parkinson’s Disease Business (2015-2020)
13.5.5 Merck Recent Development
13.6 Boehringer Ingelheim
13.6.1 Boehringer Ingelheim Company Details
13.6.2 Boehringer Ingelheim Business Overview
13.6.3 Boehringer Ingelheim Parkinson’s Disease Introduction
13.6.4 Boehringer Ingelheim Revenue in Parkinson’s Disease Business (2015-2020)
13.6.5 Boehringer Ingelheim Recent Development
13.7 Amneal + Impax
13.7.1 Amneal + Impax Company Details
13.7.2 Amneal + Impax Business Overview
13.7.3 Amneal + Impax Parkinson’s Disease Introduction
13.7.4 Amneal + Impax Revenue in Parkinson’s Disease Business (2015-2020)
13.7.5 Amneal + Impax Recent Development
13.8 Lundbeck
13.8.1 Lundbeck Company Details
13.8.2 Lundbeck Business Overview
13.8.3 Lundbeck Parkinson’s Disease Introduction
13.8.4 Lundbeck Revenue in Parkinson’s Disease Business (2015-2020)
13.8.5 Lundbeck Recent Development
13.9 Sun Pharma
13.9.1 Sun Pharma Company Details
13.9.2 Sun Pharma Business Overview
13.9.3 Sun Pharma Parkinson’s Disease Introduction
13.9.4 Sun Pharma Revenue in Parkinson’s Disease Business (2015-2020)
13.9.5 Sun Pharma Recent Development
13.10 Wockhardt
13.10.1 Wockhardt Company Details
13.10.2 Wockhardt Business Overview
13.10.3 Wockhardt Parkinson’s Disease Introduction
13.10.4 Wockhardt Revenue in Parkinson’s Disease Business (2015-2020)
13.10.5 Wockhardt Recent Development
13.11 UCB
10.11.1 UCB Company Details
10.11.2 UCB Business Overview
10.11.3 UCB Parkinson’s Disease Introduction
10.11.4 UCB Revenue in Parkinson’s Disease Business (2015-2020)
10.11.5 UCB Recent Development
13.12 Bausch Health
10.12.1 Bausch Health Company Details
10.12.2 Bausch Health Business Overview
10.12.3 Bausch Health Parkinson’s Disease Introduction
10.12.4 Bausch Health Revenue in Parkinson’s Disease Business (2015-2020)
10.12.5 Bausch Health Recent Development
13.13 Acadia
10.13.1 Acadia Company Details
10.13.2 Acadia Business Overview
10.13.3 Acadia Parkinson’s Disease Introduction
10.13.4 Acadia Revenue in Parkinson’s Disease Business (2015-2020)
10.13.5 Acadia Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Parkinson's Disease Key Market Segments
Table 2. Key Players Covered: Ranking by Parkinson's Disease Revenue
Table 3. Ranking of Global Top Parkinson's Disease Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Parkinson's Disease Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Carbidopa/Levodopa
Table 6. Key Players of Dopamine Receptor Agonists
Table 7. Key Players of MAO-Inhibitors
Table 8. Global Parkinson's Disease Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Parkinson's Disease Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Parkinson's Disease Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Parkinson's Disease Market Share by Regions (2015-2020)
Table 12. Global Parkinson's Disease Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Parkinson's Disease Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Parkinson's Disease Market Growth Strategy
Table 18. Main Points Interviewed from Key Parkinson's Disease Players
Table 19. Global Parkinson's Disease Revenue by Players (2015-2020) (Million US$)
Table 20. Global Parkinson's Disease Market Share by Players (2015-2020)
Table 21. Global Top Parkinson's Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parkinson's Disease as of 2019)
Table 22. Global Parkinson's Disease by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Parkinson's Disease Product Solution and Service
Table 25. Date of Enter into Parkinson's Disease Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Parkinson's Disease Market Size by Type (2015-2020) (Million US$)
Table 28. Global Parkinson's Disease Market Size Share by Type (2015-2020)
Table 29. Global Parkinson's Disease Revenue Market Share by Type (2021-2026)
Table 30. Global Parkinson's Disease Market Size Share by Application (2015-2020)
Table 31. Global Parkinson's Disease Market Size by Application (2015-2020) (Million US$)
Table 32. Global Parkinson's Disease Market Size Share by Application (2021-2026)
Table 33. North America Key Players Parkinson's Disease Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Parkinson's Disease Market Share (2019-2020)
Table 35. North America Parkinson's Disease Market Size by Type (2015-2020) (Million US$)
Table 36. North America Parkinson's Disease Market Share by Type (2015-2020)
Table 37. North America Parkinson's Disease Market Size by Application (2015-2020) (Million US$)
Table 38. North America Parkinson's Disease Market Share by Application (2015-2020)
Table 39. Europe Key Players Parkinson's Disease Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Parkinson's Disease Market Share (2019-2020)
Table 41. Europe Parkinson's Disease Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Parkinson's Disease Market Share by Type (2015-2020)
Table 43. Europe Parkinson's Disease Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Parkinson's Disease Market Share by Application (2015-2020)
Table 45. China Key Players Parkinson's Disease Revenue (2019-2020) (Million US$)
Table 46. China Key Players Parkinson's Disease Market Share (2019-2020)
Table 47. China Parkinson's Disease Market Size by Type (2015-2020) (Million US$)
Table 48. China Parkinson's Disease Market Share by Type (2015-2020)
Table 49. China Parkinson's Disease Market Size by Application (2015-2020) (Million US$)
Table 50. China Parkinson's Disease Market Share by Application (2015-2020)
Table 51. Japan Key Players Parkinson's Disease Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Parkinson's Disease Market Share (2019-2020)
Table 53. Japan Parkinson's Disease Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Parkinson's Disease Market Share by Type (2015-2020)
Table 55. Japan Parkinson's Disease Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Parkinson's Disease Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Parkinson's Disease Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Parkinson's Disease Market Share (2019-2020)
Table 59. Southeast Asia Parkinson's Disease Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Parkinson's Disease Market Share by Type (2015-2020)
Table 61. Southeast Asia Parkinson's Disease Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Parkinson's Disease Market Share by Application (2015-2020)
Table 63. India Key Players Parkinson's Disease Revenue (2019-2020) (Million US$)
Table 64. India Key Players Parkinson's Disease Market Share (2019-2020)
Table 65. India Parkinson's Disease Market Size by Type (2015-2020) (Million US$)
Table 66. India Parkinson's Disease Market Share by Type (2015-2020)
Table 67. India Parkinson's Disease Market Size by Application (2015-2020) (Million US$)
Table 68. India Parkinson's Disease Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Parkinson's Disease Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Parkinson's Disease Market Share (2019-2020)
Table 71. Central & South America Parkinson's Disease Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Parkinson's Disease Market Share by Type (2015-2020)
Table 73. Central & South America Parkinson's Disease Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Parkinson's Disease Market Share by Application (2015-2020)
Table 75. Teva Company Details
Table 76. Teva Business Overview
Table 77. Teva Product
Table 78. Teva Revenue in Parkinson's Disease Business (2015-2020) (Million US$)
Table 79. Teva Recent Development
Table 80. Novartis Company Details
Table 81. Novartis Business Overview
Table 82. Novartis Product
Table 83. Novartis Revenue in Parkinson's Disease Business (2015-2020) (Million US$)
Table 84. Novartis Recent Development
Table 85. GSK Company Details
Table 86. GSK Business Overview
Table 87. GSK Product
Table 88. GSK Revenue in Parkinson's Disease Business (2015-2020) (Million US$)
Table 89. GSK Recent Development
Table 90. AbbVie Company Details
Table 91. AbbVie Business Overview
Table 92. AbbVie Product
Table 93. AbbVie Revenue in Parkinson's Disease Business (2015-2020) (Million US$)
Table 94. AbbVie Recent Development
Table 95. Merck Company Details
Table 96. Merck Business Overview
Table 97. Merck Product
Table 98. Merck Revenue in Parkinson's Disease Business (2015-2020) (Million US$)
Table 99. Merck Recent Development
Table 100. Boehringer Ingelheim Company Details
Table 101. Boehringer Ingelheim Business Overview
Table 102. Boehringer Ingelheim Product
Table 103. Boehringer Ingelheim Revenue in Parkinson's Disease Business (2015-2020) (Million US$)
Table 104. Boehringer Ingelheim Recent Development
Table 105. Amneal + Impax Company Details
Table 106. Amneal + Impax Business Overview
Table 107. Amneal + Impax Product
Table 108. Amneal + Impax Revenue in Parkinson's Disease Business (2015-2020) (Million US$)
Table 109. Amneal + Impax Recent Development
Table 110. Lundbeck Business Overview
Table 111. Lundbeck Product
Table 112. Lundbeck Company Details
Table 113. Lundbeck Revenue in Parkinson's Disease Business (2015-2020) (Million US$)
Table 114. Lundbeck Recent Development
Table 115. Sun Pharma Company Details
Table 116. Sun Pharma Business Overview
Table 117. Sun Pharma Product
Table 118. Sun Pharma Revenue in Parkinson's Disease Business (2015-2020) (Million US$)
Table 119. Sun Pharma Recent Development
Table 120. Wockhardt Company Details
Table 121. Wockhardt Business Overview
Table 122. Wockhardt Product
Table 123. Wockhardt Revenue in Parkinson's Disease Business (2015-2020) (Million US$)
Table 124. Wockhardt Recent Development
Table 125. UCB Company Details
Table 126. UCB Business Overview
Table 127. UCB Product
Table 128. UCB Revenue in Parkinson's Disease Business (2015-2020) (Million US$)
Table 129. UCB Recent Development
Table 130. Bausch Health Company Details
Table 131. Bausch Health Business Overview
Table 132. Bausch Health Product
Table 133. Bausch Health Revenue in Parkinson's Disease Business (2015-2020) (Million US$)
Table 134. Bausch Health Recent Development
Table 135. Acadia Company Details
Table 136. Acadia Business Overview
Table 137. Acadia Product
Table 138. Acadia Revenue in Parkinson's Disease Business (2015-2020) (Million US$)
Table 139. Acadia Recent Development
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Parkinson's Disease Market Share by Type: 2020 VS 2026
Figure 2. Carbidopa/Levodopa Features
Figure 3. Dopamine Receptor Agonists Features
Figure 4. MAO-Inhibitors Features
Figure 5. Global Parkinson's Disease Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Parkinson's Disease Report Years Considered
Figure 9. Global Parkinson's Disease Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Parkinson's Disease Market Share by Regions: 2020 VS 2026
Figure 11. Global Parkinson's Disease Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Parkinson's Disease Market Share by Players in 2019
Figure 14. Global Top Parkinson's Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parkinson's Disease as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Parkinson's Disease Revenue in 2019
Figure 16. North America Parkinson's Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Parkinson's Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Parkinson's Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Parkinson's Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Parkinson's Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Parkinson's Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Parkinson's Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed
パーキンソン病治療の世界市場（～2026年） Parkinson's disease (PD) is a long-term degenerative disorder of the central nervous system that mainly affects the motor system. There is no cure for Parkinson's disease, with treatment directed at improving symptoms. Initial treatment is typically with the antiparkinson medication levodopa (L-DOPA…- パーキンソン病（PD）治療薬の世界市場（～2026年） Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by damage to the dopaminergic neurons located in various parts of the brain, including the substantia nigra. The emergence of gene therapy to reverse the progression of PD is one of the key trends that will gain tract…
- ウォルフパーキンソンホワイト症候群治療の世界市場（～2026年） Wolff-Parkinson-White (WPW) syndrome is a rare congenital heart disorder involving irregularities in the electrical transmission system of the heart. In WPW syndrome, an abnormal alternate electrical pathway exists resulting in arrhythmias (abnormal heartbeat rhythms) and tachycardia (faster than no…
- アルツハイマー病治療薬の世界市場（～2026年） Alzheimer’s disease is a neurodegenerative, progressive, non-reversible disorder. Alzheimer’s disease is caused due to abnormal functioning of brain cells i.e. failure of synaptic transmission, resulting in the loss of cognitive functions. Some of the signs and symptoms of alzheimer’s disease are me…
- 胃食道逆流症（GERD）治療薬の世界市場（～2026年） Gastroesophageal reflux disease (GERD), also known as acid reflux, is a long-term condition where stomach contents come back up into the esophagus resulting in either symptoms or complications. Patent expiry of blockbuster drugs prescribed for the treatment of acid reflux disorders is majorly attrib…